179 related articles for article (PubMed ID: 26081151)
1. Circulating microRNA Signatures in Rodent Models of Pain.
Qureshi RA; Tian Y; McDonald MK; Capasso KE; Douglas SR; Gao R; Orlova IA; Barrett JE; Ajit SK; Sacan A
Mol Neurobiol; 2016 Jul; 53(5):3416-3427. PubMed ID: 26081151
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNA expression profile: a novel potential predictor for chronic nervous lesions.
Xu Y; Zhang X; Pu S; Wu J; Lv Y; Du D
Acta Biochim Biophys Sin (Shanghai); 2014 Nov; 46(11):942-9. PubMed ID: 25274330
[TBL] [Abstract][Full Text] [Related]
3. Additive antinociceptive effects of the selective Nav1.8 blocker A-803467 and selective TRPV1 antagonists in rat inflammatory and neuropathic pain models.
Joshi SK; Honore P; Hernandez G; Schmidt R; Gomtsyan A; Scanio M; Kort M; Jarvis MF
J Pain; 2009 Mar; 10(3):306-15. PubMed ID: 19070548
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of rat hippocampal microRNAs in two rat models of chronic pain.
Hori Y; Goto G; Arai-Iwasaki M; Ishikawa M; Sakamoto A
Int J Mol Med; 2013 Dec; 32(6):1287-92. PubMed ID: 24065306
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drugs increase expression of inducible COX-2 isoform of cyclooxygenase in spinal cord of rats with adjuvant induced inflammation.
Hsueh SF; Lu CY; Chao CS; Tan PH; Huang YW; Hsieh SW; Hsiao HT; Chung NC; Lin SH; Huang PL; Lyu PC; Yang LC
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):113-9. PubMed ID: 15193428
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive activity of α4β2* neuronal nicotinic receptor agonist A-366833 in experimental models of neuropathic and inflammatory pain.
Nirogi R; Jabaris SL; Jayarajan P; Abraham R; Shanmuganathan D; Rasheed MA; Royapalley PK; Goura V
Eur J Pharmacol; 2011 Oct; 668(1-2):155-62. PubMed ID: 21756895
[TBL] [Abstract][Full Text] [Related]
7. Identification of lncRNA expression profile in the spinal cord of mice following spinal nerve ligation-induced neuropathic pain.
Jiang BC; Sun WX; He LN; Cao DL; Zhang ZJ; Gao YJ
Mol Pain; 2015 Jul; 11():43. PubMed ID: 26184882
[TBL] [Abstract][Full Text] [Related]
8. Expression and functional role of metallothioneins I and II in the spinal cord in inflammatory and neuropathic pain models.
Kwon A; Jeon SM; Hwang SH; Kim JH; Cho HJ
Brain Res; 2013 Jul; 1523():37-48. PubMed ID: 23726995
[TBL] [Abstract][Full Text] [Related]
9. Identifying Plasma Derived Extracellular Vesicle (EV) Contained Biomarkers in the Development of Chronic Neuropathic Pain.
Sosanya NM; Kumar R; Clifford JL; Chavez R; Dimitrov G; Srinivasan S; Gautam A; Trevino AV; Williams M; Hammamieh R; Cheppudira BP; Christy RJ; Crimmins SL
J Pain; 2020; 21(1-2):82-96. PubMed ID: 31228575
[TBL] [Abstract][Full Text] [Related]
10. Suberoylanilide hydroxamic acid prevents downregulation of spinal glutamate transporter-1 and attenuates spinal nerve ligation-induced neuropathic pain behavior.
Cui SS; Lu R; Zhang H; Wang W; Ke JJ
Neuroreport; 2016 Apr; 27(6):427-34. PubMed ID: 26953753
[TBL] [Abstract][Full Text] [Related]
11. Role of astrocytic S100beta in behavioral hypersensitivity in rodent models of neuropathic pain.
Tanga FY; Raghavendra V; Nutile-McMenemy N; Marks A; Deleo JA
Neuroscience; 2006 Jul; 140(3):1003-10. PubMed ID: 16600520
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states.
Joshi SK; Mikusa JP; Hernandez G; Baker S; Shieh CC; Neelands T; Zhang XF; Niforatos W; Kage K; Han P; Krafte D; Faltynek C; Sullivan JP; Jarvis MF; Honore P
Pain; 2006 Jul; 123(1-2):75-82. PubMed ID: 16545521
[TBL] [Abstract][Full Text] [Related]
13. L-Tetrahydropalmatine alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice.
Zhou HH; Wu DL; Gao LY; Fang Y; Ge WH
Neuroreport; 2016 May; 27(7):476-80. PubMed ID: 26981712
[TBL] [Abstract][Full Text] [Related]
14. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain.
Lindia JA; McGowan E; Jochnowitz N; Abbadie C
J Pain; 2005 Jul; 6(7):434-8. PubMed ID: 15993821
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic effects of a D-amino acid oxidase inhibitor indicate a spinal site of action in rat models of neuropathic pain.
Hopkins SC; Zhao FY; Bowen CA; Fang X; Wei H; Heffernan ML; Spear KL; Spanswick DC; Varney MA; Large TH
J Pharmacol Exp Ther; 2013 Jun; 345(3):502-11. PubMed ID: 23520265
[TBL] [Abstract][Full Text] [Related]
16. Abnormal gait, due to inflammation but not nerve injury, reflects enhanced nociception in preclinical pain models.
Piesla MJ; Leventhal L; Strassle BW; Harrison JE; Cummons TA; Lu P; Whiteside GT
Brain Res; 2009 Oct; 1295():89-98. PubMed ID: 19651113
[TBL] [Abstract][Full Text] [Related]
17. A cell-permeant peptide corresponding to the cUBP domain of USP5 reverses inflammatory and neuropathic pain.
Garcia-Caballero A; Gadotti VM; Chen L; Zamponi GW
Mol Pain; 2016; 12():. PubMed ID: 27130589
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance.
Wild KD; Bian D; Zhu D; Davis J; Bannon AW; Zhang TJ; Louis JC
J Pharmacol Exp Ther; 2007 Jul; 322(1):282-7. PubMed ID: 17431136
[TBL] [Abstract][Full Text] [Related]
19. Effects of koumine, an alkaloid of Gelsemium elegans Benth., on inflammatory and neuropathic pain models and possible mechanism with allopregnanolone.
Xu Y; Qiu HQ; Liu H; Liu M; Huang ZY; Yang J; Su YP; Yu CX
Pharmacol Biochem Behav; 2012 May; 101(3):504-14. PubMed ID: 22366214
[TBL] [Abstract][Full Text] [Related]
20. Anti-nociceptive effects of Tanshinone IIA (TIIA) in a rat model of complete Freund's adjuvant (CFA)-induced inflammatory pain.
Sun S; Yin Y; Yin X; Cao F; Luo D; Zhang T; Li Y; Ni L
Brain Res Bull; 2012 Sep; 88(6):581-8. PubMed ID: 22705002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
